Bayer Aktiengesellschaft
BAYZF
$29.19
$0.1150.40%
Weiss Ratings | BAYZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Weak | |||
Risk Index | Weak | |||
Risk Grade | D- | |||
Reward Grade | D+ | |||
Rating Factors | BAYZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | Fair | |||
Growth Index | Weak | |||
Efficiency Index | Fair | |||
Solvency Index | Good | |||
Total Return Index | Very Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | BAYZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.71 | |||
Price History | BAYZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -3.26% | |||
30-Day Total Return | -4.77% | |||
60-Day Total Return | -20.64% | |||
90-Day Total Return | -16.92% | |||
Year to Date Total Return | -26.03% | |||
1-Year Total Return | -57.97% | |||
2-Year Total Return | -59.48% | |||
3-Year Total Return | -57.00% | |||
5-Year Total Return | -60.44% | |||
52-Week High % Change | -56.38% | |||
52-Week Low % Change | 6.07% | |||
Price | BAYZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $67.19 | |||
52-Week Low Price | $27.41 | |||
52-Week Low Price (Date) | Apr 16, 2024 | |||
52-Week High Price (Date) | Apr 20, 2023 | |||
Valuation | BAYZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 27.59B | |||
Enterprise Value | 64.46B | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -3.31 | |||
Earnings Per Share Growth | -171.48% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 0.54 | |||
Price/Book (Q) | 0.76 | |||
Enterprise Value/Revenue (TTM) | 1.27 | |||
Price | $27.93 | |||
Enterprise Value/EBITDA (TTM) | 4.22 | |||
Enterprise Value/EBIT | 5.93 | |||
Market Cap Category | Large Cap | |||
Dividends and Shares | BAYZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 982.42M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -79.63% | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | BAYZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 49 214 30 1 | |||
Address | -- | |||
Website | www.bayer.com | |||
Country | Germany | |||
Year Founded | 1863 | |||
Profitability | BAYZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 21.44% | |||
Profit Margin | -6.31% | |||
Management Effectiveness | BAYZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | 5.27% | |||
Return on Equity | -- | |||
Income Statement | BAYZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 51.48B | |||
Total Revenue (TTM) | 51.48B | |||
Revenue Per Share | $52.40 | |||
Gross Profit (TTM) | 30.18B | |||
EBITDA (TTM) | 15.53B | |||
EBIT (TTM) | 11.04B | |||
Net Income (TTM) | -3.25B | |||
Net Income Avl. to Common (TTM) | -3.25B | |||
Total Revenue Growth (Q YOY) | 4.15% | |||
Earnings Growth (Q YOY) | 132.19% | |||
EPS Diluted (TTM) | -3.31 | |||
EPS Diluted Growth (Q YOY) | 131.27% | |||
Balance Sheet | BAYZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 11.70B | |||
Cash Per Share (Q) | $11.91 | |||
Total Current Assets (Q) | 41.51B | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 36.56B | |||
Current Ratio (Q) | 1.275 | |||
Book Value Per Share (Q) | $37.05 | |||
Total Assets (Q) | 128.51B | |||
Total Current Liabilities (Q) | 32.56B | |||
Total Debt (Q) | 49.75B | |||
Total Liabilities (Q) | 91.94B | |||
Total Common Equity (Q) | 36.40B | |||
Cash Flow | BAYZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -3.81B | |||
Cash from Financing (TTM) | -736.58M | |||
Net Change in Cash (TTM) | 816.88M | |||
Levered Free Cash Flow (TTM) | -3.07B | |||
Cash from Operations (TTM) | 5.56B | |||